MX2020012483A - Agente de aclaramiento de la piel. - Google Patents

Agente de aclaramiento de la piel.

Info

Publication number
MX2020012483A
MX2020012483A MX2020012483A MX2020012483A MX2020012483A MX 2020012483 A MX2020012483 A MX 2020012483A MX 2020012483 A MX2020012483 A MX 2020012483A MX 2020012483 A MX2020012483 A MX 2020012483A MX 2020012483 A MX2020012483 A MX 2020012483A
Authority
MX
Mexico
Prior art keywords
sup
skin lightening
lightening agent
hydrogen atom
branched
Prior art date
Application number
MX2020012483A
Other languages
English (en)
Inventor
Yuko Saitoh
Shoko Sassa
Yasuhito Mori
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Publication of MX2020012483A publication Critical patent/MX2020012483A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42Colour properties
    • A61K2800/43Pigments; Dyes
    • A61K2800/434Luminescent, Fluorescent; Optical brighteners; Photosensitizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

El objetivo es proporcionar un agente de blanqueamiento de la piel que tiene un excelente efecto de blanqueamiento de la piel. Un compuesto expresado por la siguiente Fórmula (1), o una sal de adición de ácido del mismo se utiliza como un ingrediente activo del agente de blanqueamiento de la piel: (ver Fórmula) en donde, X representa un grupo alquileno que tiene 1 a 2 átomos de carbono, donde un átomo de hidrógeno puede ser sustituido con un grupo metilo; Y representa COOR1 o CH2OR2; R1 representa un átomo de hidrógeno, o un grupo alquilo opcionalmente ramificado que tiene 1 a 6 átomos de carbono; y R2 representa un átomo de hidrógeno o un grupo acilo opcionalmente ramificado que tiene 1 a 6 átomos de carbono.
MX2020012483A 2018-05-29 2019-04-24 Agente de aclaramiento de la piel. MX2020012483A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018101963 2018-05-29
PCT/JP2019/017350 WO2019230274A1 (ja) 2018-05-29 2019-04-24 美白剤

Publications (1)

Publication Number Publication Date
MX2020012483A true MX2020012483A (es) 2021-02-15

Family

ID=68696707

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020012483A MX2020012483A (es) 2018-05-29 2019-04-24 Agente de aclaramiento de la piel.

Country Status (15)

Country Link
US (1) US20210196599A1 (es)
EP (1) EP3804690B1 (es)
JP (1) JP7239573B2 (es)
KR (1) KR102513180B1 (es)
CN (1) CN112135599B (es)
AU (1) AU2019278251B2 (es)
BR (1) BR112020023802B1 (es)
CA (1) CA3101313C (es)
IL (1) IL278816B2 (es)
MX (1) MX2020012483A (es)
RU (1) RU2757906C1 (es)
SG (1) SG11202011525WA (es)
TW (1) TW202015653A (es)
UA (1) UA126100C2 (es)
WO (1) WO2019230274A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021054820A (ja) * 2019-09-30 2021-04-08 花王株式会社 日焼け止め化粧料

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6036418B2 (ja) * 1980-07-21 1985-08-20 帝人株式会社 アミノカルボン酸誘導体、その製造法及びそれを活性成分とする抗潰瘍剤
JPS5846049A (ja) * 1981-09-11 1983-03-17 Teijin Ltd アミノカルボン酸誘導体およびその製造法
JPS63270650A (ja) * 1987-04-30 1988-11-08 Asahi Chem Ind Co Ltd P−(トランス−4−アミノメチルシクロヘキシルカルボニル)フエニルプロピオン酸の製造方法
JPS644508A (en) 1987-06-26 1989-01-09 Daihatsu Motor Co Ltd Hood lock structure of van type vehicle
JP2999203B2 (ja) * 1989-08-29 2000-01-17 第一製薬株式会社 日腔用組成物
JP3083912B2 (ja) 1992-06-18 2000-09-04 株式会社田中製作所 レーザ加工装置
JP2974412B2 (ja) * 1993-07-30 1999-11-10 帝人株式会社 ペプチド,蛋白質性薬物経鼻粉剤
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions
CN101378724A (zh) * 2006-02-14 2009-03-04 宝丽化学工业有限公司 皮肤增白化妆品
DE102006019044A1 (de) * 2006-04-25 2007-10-31 Merck Patent Gmbh Antioxidantien
JP5133645B2 (ja) * 2006-10-02 2013-01-30 第一三共ヘルスケア株式会社 セトラキサートを含有する美白剤
JP5462504B2 (ja) * 2008-03-21 2014-04-02 第一三共ヘルスケア株式会社 美白用組成物
US9050293B2 (en) * 2008-07-16 2015-06-09 Juventio, Llc Small molecule solubilization system
US20120258063A1 (en) * 2009-12-16 2012-10-11 Pola Chemical Industries Inc. Preventing or ameliorating agent for pigmentation
JP5911209B2 (ja) * 2011-06-14 2016-04-27 ポーラ化成工業株式会社 皮膚外用剤
JP5846049B2 (ja) * 2012-06-06 2016-01-20 新日鐵住金株式会社 焼結鉱の製造方法
EP3545944B1 (en) * 2016-11-28 2022-12-28 Pola Chemical Industries Inc. Wrinkle ameliorating agent

Also Published As

Publication number Publication date
AU2019278251A1 (en) 2020-12-10
US20210196599A1 (en) 2021-07-01
CA3101313C (en) 2023-01-24
IL278816A (en) 2021-01-31
CA3101313A1 (en) 2019-12-05
UA126100C2 (uk) 2022-08-10
BR112020023802A2 (pt) 2021-02-23
JP7239573B2 (ja) 2023-03-14
NZ770176A (en) 2024-02-23
AU2019278251B2 (en) 2021-12-16
EP3804690A1 (en) 2021-04-14
WO2019230274A1 (ja) 2019-12-05
JPWO2019230274A1 (ja) 2021-06-17
KR20210003827A (ko) 2021-01-12
TW202015653A (zh) 2020-05-01
KR102513180B1 (ko) 2023-03-23
RU2757906C1 (ru) 2021-10-22
BR112020023802B1 (pt) 2023-10-31
EP3804690A4 (en) 2022-06-08
IL278816B2 (en) 2023-11-01
EP3804690B1 (en) 2024-06-05
IL278816B1 (en) 2023-07-01
CN112135599B (zh) 2023-03-31
SG11202011525WA (en) 2020-12-30
CN112135599A (zh) 2020-12-25

Similar Documents

Publication Publication Date Title
UY38297A (es) Compuestos derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-diona, composiciones, métodos y usos de los mismos
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
RS53451B (en) INHIBITORI P70 S6 KINAZE
HUP0301607A2 (hu) Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AR060545A1 (es) Compuestos de benzoaxol y benzotiazol 6-0- sustituidos y metodos de inhibicion de la senalizacion de csf-1r. composiciones farmaceuticas
TW200612920A (en) Novel imidazolidine derivatives
TW200745058A (en) MMP-13 selective inhibitors
ZA200601595B (en) Aminopyrones and their use as ATM inhibitors
PH12018502012A1 (en) Griseofulvin compound
DK1485377T5 (da) Pyranoner egnede som ATM-inhibitorer
UY37764A (es) Nuevos compuestos inhibidores de la prostaglandina d sintasa hematopoyética (h-pgds)
MX2013007938A (es) Compuesto biciclico novedoso o sal del mismo.
AR057464A1 (es) Procedimiento para la preparacion de derivados de sulfonamida
MX2013007296A (es) Derivado novedoso de isoquinolina sustituido.
MX2021012145A (es) Composiciones antifungicas.
SE0201658D0 (sv) Immediate release pharmaceutical formulation
CR7249A (es) Derivados de diamina, proceso para producir los derivados de diamina, y funguicidas que contienen los derivados de diamina como ingrediente activo
HUP0303279A2 (hu) Indolo-pirrolo-karbazolok cukorszármazékai, mint topoizomeráz inhibitorok és ezeket tartalmazó gyógyszerkészítmények
MX2020012483A (es) Agente de aclaramiento de la piel.
SE7710395L (sv) Bekempningsmedel mot skadegorare
RS53965B1 (en) ACILBENZENA DERIVATIVES
MX2017003822A (es) Compuestos de piridina.
IN2012DN01251A (es)
MX2019006108A (es) Agente de mejoramiento de arrugas.
AR083489A1 (es) Composicion de control de plagas